---
pmid: '16166283'
title: Primary cutaneous T-cell lymphomas show a deletion or translocation affecting
  NAV3, the human UNC-53 homologue.
authors:
- Karenko L
- Hahtola S
- Päivinen S
- Karhu R
- Syrjä S
- Kähkönen M
- Nedoszytko B
- Kytölä S
- Zhou Y
- Blazevic V
- Pesonen M
- Nevala H
- Nupponen N
- Sihto H
- Krebs I
- Poustka A
- Roszkiewicz J
- Saksela K
- Peterson P
- Visakorpi T
- Ranki A
journal: Cancer Res
year: '2005'
full_text_available: false
doi: 10.1158/0008-5472.CAN-04-0366
---

# Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.
**Authors:** Karenko L, Hahtola S, Päivinen S, Karhu R, Syrjä S, Kähkönen M, Nedoszytko B, Kytölä S, Zhou Y, Blazevic V, Pesonen M, Nevala H, Nupponen N, Sihto H, Krebs I, Poustka A, Roszkiewicz J, Saksela K, Peterson P, Visakorpi T, Ranki A
**Journal:** Cancer Res (2005)
**DOI:** [10.1158/0008-5472.CAN-04-0366](https://doi.org/10.1158/0008-5472.CAN-04-0366)

## Abstract

1. Cancer Res. 2005 Sep 15;65(18):8101-10. doi: 10.1158/0008-5472.CAN-04-0366.

Primary cutaneous T-cell lymphomas show a deletion or translocation affecting 
NAV3, the human UNC-53 homologue.

Karenko L(1), Hahtola S, Päivinen S, Karhu R, Syrjä S, Kähkönen M, Nedoszytko B, 
Kytölä S, Zhou Y, Blazevic V, Pesonen M, Nevala H, Nupponen N, Sihto H, Krebs I, 
Poustka A, Roszkiewicz J, Saksela K, Peterson P, Visakorpi T, Ranki A.

Author information:
(1)Department of Dermatology and Venereology, Helsinki University Central 
Hospital, University of Helsinki, Helsinki, Finland. leena.p.karenko@hus.fi

Erratum in
    Cancer Res. 2008 Sep 15;68(18):7692.

Multicolor fluorescent in situ hybridization (FISH) was used to identify 
acquired chromosomal aberrations in 12 patients with mycosis fungoides or Sézary 
syndrome, the most common forms of primary cutaneous T-cell lymphoma (CTCL). The 
most frequently affected chromosome was 12, which showed clonal deletions or 
translocations with a break point in 12q21 or 12q22 in five of seven consecutive 
Sézary syndrome patients and a clonal monosomy in the sixth patient. The break 
point of a balanced translocation t(12;18)(q21;q21.2), mapped in the minimal 
common region of two deletions, fine mapped to 12q2. By locus-specific FISH, the 
translocation disrupted one gene, NAV3 (POMFIL1), a human homologue of unc-53 in 
Caenorhabditis elegans. A missense mutation in the remaining NAV3 allele was 
found in one of six cases with a deletion or translocation. With locus-specific 
FISH, NAV3 deletions were found in the skin lesions of four of eight (50%) 
patients with early mycosis fungoides (stages IA-IIA) and in the skin or lymph 
node of 11 of 13 (85%) patients with advanced mycosis fungoides or Sézary 
syndrome. Preliminary functional studies with lentiviral small interfering 
RNA-based NAV3 silencing in Jurkat cells and in primary lymphocytes showed 
enhanced interleukin 2 expression (but not CD25 expression). Thus, NAV3 may 
contribute to the growth, differentiation, and apoptosis of CTCL cells as well 
as to the skewing from Th1-type to Th2-type phenotype during disease 
progression. NAV3, a novel putative haploinsufficient tumor suppressor gene, is 
disrupted in most cases of the commonest types of CTCL and may thus provide a 
new diagnostic tool.

DOI: 10.1158/0008-5472.CAN-04-0366
PMID: 16166283 [Indexed for MEDLINE]
